We have read with interest the recent study by van Rongen et al. comparing midazolam clearance in obese adolescents with morbidly obese adults [1] . The authors attributed a higher midazolam clearance in the obese adolescents group to higher cytochrome P450 3A enzyme activity when compared to the morbidly obese adults group. However, the surgery type in the obese adults appears to have been exclusively laparoscopic procedures, whereas the surgery in the obese adolescents appears to have been predominantly orthopaedic and otolaryngeal procedures [2, 3] . Laparoscopy, with the associated pneumoperitoneum, has been shown to decrease portal venous blood flow by approximately half, with a paradoxical increase in hepatic artery blood flow by approximately 20%, and apparent effects on drug clearance [4] . This effect could also account for the apparent differences in clearance between obese adolescents and morbidly obese adults in the van Rongen et al. study. Depending on the relative timing of the dosing and the onset of the pneumoperitoneum, the effect could also mimic structural pharmacokinetic model elements, such as an extra compartment, as described in Brill et al. [3]. Have the authors considered these effects in the development of the structural model and also the covariate modelling? Some patients in the obese adolescents group underwent bariatric surgery. If these procedures were laparoscopic, then it would be interesting to explore the influence of surgery type on drug clearance. It would also be interesting to model intraperitoneal pressure during laparoscopy, if these data are available, as a covariate effect.
